Über uns

OmicScouts is a world leader in mass spectrometry-based proteomics, and integrates excellent research expertise and innovative technologies for drug and biomarker discovery.

We provide and develop proteome-wide assays that work with native proteins in a physiological setting. Our technologies can identify small molecule drug targets, target engagement markers, molecular mechanisms of action and drug response biomarkers.

OmicScouts has a track record in delivering significant collaborations with top pharmaceutical and biotechnology companies.